XRAY - NASDAQ
DENTSPLY SIRONA Inc.
$9.64
-3.8%DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
At a Glance
Live SnapshotDENTSPLY SIRONA Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
DENTSPLY SIRONA Inc. Income Statement
XRAY • NASDAQ
| DENTSPLY SIRONA Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
3.7B | 3.8B | 4B | 3.9B | 4.2B | 3.3B | 4B | 4B | 4B | 3.7B | 2.7B | 2.9B | 3B | 2.9B | 2.5B | 2.2B | 2.2B | 2.2B | 2B | 1.8B | |
GROSS PROFIT | ||||||||||||||||||||
(1.8B) | (1.8B) | (1.9B) | (1.8B) | (1.9B) | (1.7B) | (1.9B) | (1.9B) | (1.8B) | (1.7B) | (1.2B) | (1.3B) | (1.4B) | (1.4B) | (1.3B) | (1.1B) | (1B) | (1B) | (969.1M) | (881.5M) | |
1.8B | 2B | 2.1B | 2.1B | 2.3B | 1.7B | 2.2B | 2.1B | 2.2B | 2B | 1.5B | 1.6B | 1.6B | 1.6B | 1.3B | 1.1B | 1.1B | 1.2B | 1B | 929M | |
OPERATING INCOME | ||||||||||||||||||||
(1.6B) | (2.8B) | (2.2B) | (3.1B) | (1.7B) | (1.7B) | (1.8B) | (1.7B) | (1.7B) | (1.5B) | (1.1B) | (1.1B) | (1.1B) | (1.1B) | (936.8M) | (738.9M) | (723.2M) | (739.2M) | (680.5M) | (603M) | |
(1.4B) | (1.6B) | (1.6B) | (1.6B) | (1.6B) | (1.3B) | (1.6B) | (1.7B) | (1.7B) | (1.5B) | (1.1B) | (1.1B) | (1.1B) | (1.1B) | (936.8M) | (738.9M) | (723.2M) | (739.2M) | (675.4M) | (606.4M) | |
(150M) | (165M) | (184M) | (174M) | (171M) | (123M) | (143M) | (160.5M) | (151.7M) | (128.5M) | (74.9M) | (80.8M) | (85.1M) | (85.4M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
252M | -879M | -85M | -937M | 608M | -3M | 353M | -958.1M | -1.6B | 454.7M | 375.2M | 445.6M | 419.2M | 381.9M | 300.7M | 380.3M | 381.2M | 380.4M | 354.9M | 314.8M | |
PRE-TAX INCOME | ||||||||||||||||||||
(88M) | (69M) | (81M) | (65M) | (61M) | (62M) | (29.4M) | (37.3M) | (38.3M) | (35.9M) | (55.9M) | (46.9M) | (49.6M) | (56.9M) | (44.6M) | (25.1M) | (17.8M) | (32.5M) | (12M) | (10.8M) | |
-88M | -69M | -81M | -65M | -61M | -61M | -27M | -35M | -35.9M | -33.9M | -53.7M | -41.3M | -41.5M | -48.1M | -35.6M | -20.8M | -16.9M | -15.4M | 2.6M | 1.7M | |
(0.0) | (1.1B) | (374M) | (1.3B) | (17M) | (234M) | (81M) | (1.3B) | (2.1B) | (44.1M) | (81.2M) | (11.1M) | (13.4M) | -490K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -3.4M | |
-738M | -57M | -90M | -118M | -63M | -47M | -15M | -400K | -41.2M | -13.8M | -45.5M | -41.2M | -49.9M | -51.3M | -44.6M | -22.6M | -17.8M | -24.9M | 3.2M | 43K | |
-486M | -936M | -175M | -1.1B | 545M | -50M | 338M | -958.4M | -1.6B | 440.9M | 329.7M | 404.4M | 369.3M | 330.7M | 256.1M | 357.7M | 363.4M | 355.5M | 358.1M | 314.8M | |
NET INCOME | ||||||||||||||||||||
(112M) | -26M | -43M | -105M | (134M) | (23M) | (82M) | (52.5M) | -53.2M | (9.5M) | (77M) | (81.1M) | (52.2M) | (8.9M) | -11M | (89.2M) | (88.9M) | (71.6M) | (98.5M) | (91.1M) | |
-598M | -910M | -132M | -950M | 411M | -73M | 256M | -1B | -1.6B | 429.9M | 251.2M | 322.9M | 313.2M | 314.2M | 244.5M | 265.7M | 274.3M | 283.9M | 259.7M | 223.7M |
SEC Filings
XRAY - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 14, 2026 | January 14, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 13, 2026 | January 10, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 31, 2025 | December 24, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 25, 2025 | November 25, 2025 | 2025 |
Related Guides
Continue your XRAY research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.